The Michael Matters Foundation, Inc.
was founded in honor of a wonderful father,
husband and man, Michael P. Schostok, who
succumbed to a Glioblastoma Brain Tumor at a young age.

Our Foundation’s mission is to increase public awareness of this disease, and raise funds to provide desperately needed financial assistance to Chicago area individuals and their family members who suffer from the inevitable impacts of brain cancer.

The Michael Matters Grant

You Are Making a Difference

The Michael Matters Foundation partnered with NorthShore University HealthSystems in 2014 to create a grant providing financial assistance to brain cancer patients receiving care at the NorthShore University HealthSystem Kellogg Cancer Center, located at Evanston Hospital.  In 2015, we completed a similar partnership with Northwestern Medicine Chicago Proton Center at Central DuPage Hospital, located in Warrenville, Illinois. 

Both grants are designed to help patients maintain their quality of life during their treatment. To date, more than $100,000.00 has been donated to these Michael Matters Grants, and more than a dozen families have been positively impacted by these funds. Your donations matter and make a difference. Read about how past donations have mattered and impacted families in-need. 

Learn the Impact of Donations

Words from our friends

Purchase Your Tickets Today!

New Year Same Wish Fundraising Event 2016

February 5, 2016
The Michael Matters Foundation proudly hosts its 3rd annual “New Year, Same Wish”, a fundraising event which directly benefits Chicagoland individuals who are suffer from the impacts of brain cancer. Friends and supporters of The Michael Matters Foundation, 21 and older, are...
Read More
View Info
0% Donated/$100,000 To Go

Donate to the foundation!

Make a regular donation. Secure and easy. We care about your privacy. 

Donate Now!

A Message from Dr. Merrell

Poliovirus for Glioblastoma – What’s all the buzz?

dr-ryan-merrellA recent story on 60 Minutes profiled a novel treatment for glioblastoma using an attenuated polio virus.  The program highlighted two patients treated on the clinical trial who achieved seemingly spectacular outcomes. These patients were more than three years out from when their tumors grew back.  Is this the holy grail for curing glioblastoma?  Should we be sending all of our patients for the poliovirus trial at Duke?

Read More



Join the Michael Matters Community